iquid biopsy in mamma carcinoma

• Conditions: mamma carcinoma; metastasized triple negative mammacarcinoma; 10006291

• Registration Number: NL-OMON51488
• Lead Sponsor: Zuyderland Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

- patients with a metastasized mammacarcinoma

Exclusion Criteria

- no other malignancies
- no biopt of the primary tumor
- patients younger than 16 years
- no informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- relation between de absence/presence of specific PIK3CA mutations in blood vs<br /><br>primary tumor </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- relation between de absence/presence of specific PIK3CAmutations in urine vs<br /><br>peripheral blood </p><br>